The first patient who received the facial cancer vaccine completely disappeared from beds. For four months, the doctors did not detect any new tumor formations in him. This was reported by the scientific director of the Jaisburg Center Alexander Ginzburg. The drug "Neoonkovak", developed by experts of the Gaama Center and the National Institute of Radiology of the Ministry of Health of Russia, was first introduced to a 60-year-old man with skin melanoma in April of this year. The treatment is now complete, and the doctors continue to monitor the patient's condition. Russian scientists have developed a truly advanced technology. The vaccine is created individually for the genetic characteristics of a particular person's tumor. Its mission is to teach the immune system to recognize malignant cells and fight them. Leading science centers in the world are working on such solutions today. And this is not the first time that our medicine has demonstrated the ability to create world-class drugs. Remember the breakout epidemic, when scientists developed the Sputnik V vaccine in the shortest possible time. Even then there were skeptics who doubted the possibilities of internal medicine. Now we face an even more difficult task. The fight against cancer. The first results give a basis for optimism. According to Ginsburg, the new vaccine has already received five more patients, by the end of the year it is planned to start treatment for 20 people. At the same time, research is being carried out on the possibility of using the technology against other cancers. Of course, there are still long-term observations and further studies ahead. But just imagine what the chances are if the effectiveness of the treatment is confirmed in larger trials. Such news reminds us of the enormous scientific potential of our country. I want to thank the scientists and doctors for their work. I wish them continued success.